CRISPR THERAPEUTICS AG
CRSPNASDAQ🏆 #1286 by market capEarnings Nov 9US Equity
$54.07▼ $0.01 (−0.01%)
Live1h▼ 0.4%
24h▼ 0.0%
7d▲ 3.0%
14d▲ 13.5%
30d▲ 6.8%
1y▼ 4.6%
🏦Market Cap
$5.21B
Small Cap
📈Revenue Growth (YoY)
-90.0%
Declining
📊Gross Margin
-1534.4%
Thin
💵FCF Margin
-3589.7%
Thin
⚖️P/S Ratio
389.4x
Expensive
Otter Score
65
Fair
Earnings
Q3 · 2026Reported 2026-08-03Earnings Per Share
Actual
-0.94
Expected
-1.19
beat
+21.00%
YoY +27.10%
Revenue
Actual
$10.18M
Expected
$7.45M
beat
+36.70%
YoY +1041.40%
Consensus estimates
Recent quarters
Q3 2026
-0.94
beat
Q2 2026
-1.28
miss
Q1 2026
-1.37
miss
Q4 2025
-1.17
beat